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Last year”, we commented on the emerging concept of 
‘chemical biology’, and our sense that the community of 
researchers in this field had begun to define itself in the 
pages of Cdem&ry 63 Biology. Since then, chemical biology 
seems to have become a very popular term - it is 
frequently discussed by a wide range of researchers 
including organic chemists, biochemists, molecular 
biologists and cell biologists, and the phrase is perhaps 
particularly familiar to reviewers of grant applications. But 
the field of chemical biology is still new, and poorly 
defined, and the words mean different things to different 
people. To some, this vagueness is not worrying - one of 
the most visible researchers in the field recently 
commented to one of us that although the name of his 
institute has an unclear meaning, at least it sounds good. 
Chemical biology is, indeed, an attractive term. But it 
seems to us important to define it, if only to gain a clearer 
sense of what it is not. All the papers published in 
Chemistry B Biology have, in our opinion, reported studies 
in chemical biology. The work we have seen in the 
journal in the past year has been notable for its variety; it 
has touched on almost every area of biology, and used a 
huge variety of synthetic, structural, analytical and 
biological techniques. What is it that makes these diverse 
studies part of the same field? 
Part of the answer lies in the aim of the research. 
Researchers in chemical biology come from a wide range 
of chemical disciplines, but all use their varied skills to 
approach problems in biology. The term ‘molecular 
biology’ must have seemed similarly vague when the 
(essentially chemical) tools of that discipline were new to 
biological researchers. Chemical biology powerfully 
complements molecular biology; while molecular biology 
allows the function of biological molecules such as 
proteins and nucleic acids to be altered by mutation, 
chemical biology directly alters the function of biological 
molecules by chemical means, for example by using small 
molecules or designed molecules as ligands. To us. this is 
the core of the field of chemical biology. 
This description of chemical biology implies that it is a 
field entirely populated by chemists; biologists appear to 
be excluded by their lack of chemical training. This is 
largely, but not entirely true. Some biological disciplines 
- notably structural biology and molecular biology - 
provide insights into the chemical nature of biological 
processes, or ways to produce novel ligands that can be 
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used as biological probes, and these disciplines therefore 
provide natural routes into chemical biology. For 
biologists with other types of training the transition is 
harder. Yet the intense interest in the field is shown by 
the fact that many biological departments and laboratories 
are attempting to acquire the necessary chemical skills by 
hiring organic chemists with a commitment to biological 
research, and a few pioneers from diverse biological 
disciplines are even taking the major step of learning 
‘hard-core’ synthetic organic chemistry themselves. The 
variety and scope of the field, and the diversity of 
researchers working in the area, seems certain to increase 
as time goes on. 
In recognition of the increasing importance of chemical 
biology, Current Biology Ltd, our publishers, have 
recently decided to launch a new member of the popular 
Current Opinion series, Current Opinion in Chemical 
Biology, edited by Donald Hilvert and Steven Ley. 
Although this new journal will be entirely separate from 
Chemistry @‘Biology, the combination of these two journals 
should be a powerful resource for our community. We 
wish Don and Steve the best in their new venture, which 
seems certain to be a success. 
The New Year has brought several changes to the 
organization of Chemistry B Biology. A number of editorial 
board members have retired, having completed their 
two-year term of office, and we have taken the 
opportunity to add some new expertise in a variety of 
areas: Juli Feigon, Bernd Giese, Barbara Imperiali, Josef 
Jiricny, Laura Kiessling, Thomas Kodadek, Steven Ley, 
Garry Nolan, William Pryor and Lars Terenius have all 
agreed to provide advice and input in their respective 
areas. We are most grateful for the past support of the 
retiring board members, and for the enthusiasm of the 
new ones. 
A more noticeable change for many of our readers and 
authors is that the journal is now produced in London 
instead of San Francisco. This change brings Chemistry & 
Biology into close proximity with its sister journals 
(covered each month in Elsewhere in Biology), Current 
Biology, Structure and Folding@ Design. Although the move 
has had its traumatic aspects for our editorial staff, we are 
proud that the service we deliver to our authors has not 
suffered: manuscripts have been handled with the same 
speed and skill, and produced to the same high quality, on 
both sides of the Atlantic. We would like to pay particular 
tribute to the outgoing in-house editors, Michael Rossner 
and William Wells, and to Jacqueline Bruszewki-Walters, 
the outgoing editorial coordinator, for their commitment 
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to the smooth transfer of the journal in difficult 
circumstances. We are also grateful for the efforts of the 
new in-house editors, Drs Emma Roberts and Frances 
Jackson, and the rest of the team in London who have had 
the very challenging task of getting up to speed with 
perhaps the fastest rapid-publication in print. Drs Rossner 
and Wells, in particular, have taken a valuable part in 
shaping the journal, and we are extremely sorry to lose 
them. Happily, Dr Wells will continue to contribute to 
the journal in the ‘Innovations’ column, introduced in this 
issue, which focuses on the new technologies developed 
in industrial settings. 
Finally, we are pleased to announce that, beginning with 
this issue, Chemistq d Biology will be indexed by 
Medline/Index Medicus. Medline has increasingly high 
standards for listing new journals, especially those that do 
not cover core medical subjects, and this decision thus 
recognizes the quality and general interest of the journal. 
It is also an important step in our campaign to ensure that 
papers in Chemistry 63 Biology are as widely visible as 
possible. All Chemistry &Y Biology articles published to date 
are, of course, available on the World Wide Web via 
BioMedNet at http://biomednet.com/cbiology/cmb.htm; 
the site provides both abstracts (which are free to all 
visitors) and full text (for which there is a charge for 
non-subscribers). 
